sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Ponesimod

Medicine · Sphingosine 1-phosphate Receptor Modulator

Ponesimod

PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Medication guideLabel updated 2025-12-04

Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗

Drug facts

Used for
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
How to take it
" Call your healthcare provider if you experience the following symptoms of slow heart rate: dizziness shortness of breath…

What it is used for

PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PONVORY is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

The most important thing to know

PONVORY may cause serious side effects, including: Infections. PONVORY can increase your risk of serious infections that can be life-threatening and cause death. PONVORY lowers the number of white blood cells (lymphocytes) in your blood. This will usually go back to normal within 1 to 2 weeks of stopping treatment. Your healthcare provider should review a recent blood test of your white blood cells before you start taking PONVORY.

Call your healthcare provider right away if you have any of these symptoms of an infection during treatment with PONVORY and for 1 to 2 weeks after your last dose of PONVORY: fever tiredness body aches chills nausea vomiting headache with fever, neck stiffness, sensitivity to light, nausea, or confusion (these may be symptoms of meningitis, an infection of the lining around your brain and spine) Your healthcare provider may delay starting or may stop your PONVORY treatment if you have an infection.

Slow heart rate (bradycardia or bradyarrhythmia) when you start taking PONVORY. PONVORY can cause your heart rate to slow down, especially after you take your first dose. You should have a test to check the electrical activity of your heart called an electrocardiogram (ECG) before you take your first dose of PONVORY. Only start your treatment with PONVORY using the Starter Pack.

You must use the PONVORY Starter Pack to slowly increase the dose over a 14-day period to help reduce the effect of slowing of your heart rate. It is important to follow the recommended dosing instructions. See "

How to take it

" Call your healthcare provider if you experience the following symptoms of slow heart rate: dizziness shortness of breath lightheadedness confusion feeling like your heart is beating slowly or skipping beats chest pain tiredness Follow directions from your healthcare provider when starting PONVORY and when you miss a dose.

See " How should I take PONVORY? " See " What are possible side effects of PONVORY? " for more information about side effects. What is PONVORY? PONVORY is a prescription medicine that is used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

It is not known if PONVORY is safe and effective in children.

Side effects, and when to stop

PONVORY may cause serious side effects, including: breathing problems. Some people who take PONVORY have shortness of breath. Call your healthcare provider right away if you have new or worsening breathing problems. liver problems. PONVORY may cause liver problems. Your healthcare provider should do blood tests to check your liver before you start taking PONVORY.

Call your healthcare provider right away if you have any of the following symptoms of liver problems: unexplained nausea vomiting stomach (abdominal) pain tiredness loss of appetite yellowing of the whites of your eyes or skin dark urine increased blood pressure. Your healthcare provider should check your blood pressure during treatment with PONVORY.

types of skin cancer, including basal cell carcinoma, melanoma, and squamous cell carcinoma. Tell your healthcare provider if you have any changes in the appearance of your skin, including changes in a mole, a new darkened area on your skin, a sore that does not heal, or growths on your skin, such as a bump that may be shiny, pearly white, skin-colored, or pink.

Your doctor should check your skin for any changes at the start of and during treatment with PONVORY. Limit the amount of time you spend in sunlight and ultraviolet (UV) light. Wear protective clothing and use a sunscreen with a high sun protection factor. a problem with your vision called macular edema. Macular edema can cause some of the same vision symptoms as a multiple sclerosis (MS) attack (optic neuritis).

You may not notice any symptoms with macular edema. Your healthcare provider should test your vision around the time you start taking PONVORY, periodically while you continue taking PONVORY, and any time you notice vision changes during treatment with PONVORY. Your risk of macular edema is higher if you have diabetes or have had an inflammation of your eye called uveitis.

Call your healthcare provider right away if you have any of the following symptoms: blurriness or shadows in the center of your vision a blind spot in the center of your vision sensitivity to light unusually colored (tinted) vision swelling and narrowing of the blood vessels in your brain. A condition called Posterior Reversible Encephalopathy Syndrome (PRES) has happened with drugs in the same class.

Symptoms of PRES usually get better when you stop taking PONVORY. However, if left untreated, it may lead to a stroke. Call your healthcare provider right away if you have any of the following symptoms: sudden severe headache sudden confusion sudden loss of vision or other changes in your vision seizure severe worsening of multiple sclerosis after stopping PONVORY.

When PONVORY is stopped, symptoms of MS may return and become worse compared to before or during treatment. Always talk to your healthcare provider before you stop taking PONVORY for any reason. Tell your healthcare provider if you have worsening symptoms of MS after stopping PONVORY. The most common side effects of PONVORY include: upper respiratory tract infections elevated liver enzymes (abnormal liver tests) high blood pressure These are not all of the possible side effects of PONVORY.

For more information, ask your healthcare provider or pharmacist. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Who should not take it

Do not take PONVORY if you: have had a heart attack, chest pain called unstable angina, stroke or mini-stroke (transient ischemic attack or TIA), or certain types of heart failure in the last 6 months. have certain types of heart block or irregular or abnormal heartbeat (arrhythmia), unless you have a pacemaker. Talk to your healthcare provider before taking PONVORY if you have any of these conditions, or do not know if you have any of these conditions.

Before you take PONVORY, tell your healthcare provider about all of your medical conditions, including if you: have a fever or infection, or you are unable to fight infections due to a disease or taking medicines that weaken your immune system. have had chicken pox or have received the vaccine for chicken pox. Your healthcare provider may do a blood test for chicken pox virus.

You may need to get the full course of vaccine for chicken pox and then wait 1 month before you start taking PONVORY. have slow heart rate. have an irregular or abnormal heartbeat (arrhythmia). have a history of stroke. have heart problems, including a heart attack or chest pain. have breathing problems, including during your sleep (sleep apnea).

have liver problems. have high blood pressure. had or now have any types of skin cancer, including basal cell carcinoma (BCC), melanoma, or squamous cell carcinoma (SCC). have eye problems, especially an inflammation of the eye called uveitis. have diabetes. are pregnant or plan to become pregnant. PONVORY may harm your unborn baby.

Talk with your healthcare provider if you are pregnant or plan to become pregnant. If you are a woman who can become pregnant, you should use effective birth control during your treatment with PONVORY and for 1 week after you stop taking PONVORY. Talk to your healthcare provider about what method of birth control is right for you during this time.

Tell your healthcare provider right away if you do become pregnant while taking PONVORY or within 1 week after you stop taking PONVORY. are breastfeeding or plan to breastfeed. It is not known if PONVORY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take PONVORY.

Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements. Using PONVORY and other medicines together may affect each other causing serious side effects. Especially tell your healthcare provider if you take or have taken: medicines to control your heart rhythm (antiarrhythmics), or blood pressure (antihypertensives), or heart beat (such as calcium channel blockers or beta-blockers).

medicines that affect your immune system, such as alemtuzumab. You should not receive live vaccines during treatment with PONVORY, for at least 1 month before taking PONVORY, and for 1 to 2 weeks after you stop taking PONVORY. If you receive a live vaccine, you may get the infection the vaccine was meant to prevent. Vaccines may not work as well when given during treatment with PONVORY.

Talk with your healthcare provider if you are not sure if you take any of these medicines. Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist when you get a new medicine. How should I take PONVORY? You will receive a 14-day starter pack. You must start PONVORY by slowly increasing doses over the first two weeks.

Follow the dose schedule in the table below. This may reduce the risk of slowing of the heart rate. Starter Pack Day Daily Dose Day 1 2 mg tablet 1 time a day Day 2 2 mg tablet 1 time a day Day 3 3 mg tablet 1 time a day Day 4 3 mg tablet 1 time a day Day 5 4 mg tablet 1 time a day Day 6 4 mg tablet 1 time a day Day 7 5 mg tablet 1 time a day Day 8 6 mg tablet 1 time a day Day 9 7 mg tablet 1 time a day Day 10 8 mg tablet 1 time a day Day 11 9 mg tablet 1 time a day Day 12 10 mg tablet 1 time a day Day 13 10 mg tablet 1 time a day Day 14 10

Storing it

Store PONVORY at room temperature between 68°F to 77°F (20°C to 25°C). Store PONVORY in the original package. The bottle of PONVORY contains a desiccant sachet to help keep your medicine dry (protect it from moisture). Do not throw away (discard) the desiccant. Keep PONVORY and all medicines out of the reach of children.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Ponesimod; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/ponesimod

APA 7th

sofidex. (2026, August 2). Ponesimod. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/ponesimod

AMA 11th

Ponesimod. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/ponesimod

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.